SCS wins media patent
Thursday, 10 July, 2008
Stem Cell Sciences [ASX: STC] has been granted a UK Patent Office patent for the company's new range of stem cell culture media.
The patent covers the company's Culticell iSTEM range, which contains a combination of enzyme inhibitors. The range is based on technology described in Nature recently by stem cell research pioneer Professor Austin Smith, now at Cambridge University, who is chair of the company's scientific advisory board.
Smith discovered that with the inhibition of key enzymes in specific combinations it is possible to produce pluripotent stem cells without feeder cells, growth factors, leukaemia inhibitory factor or serum.
The patent covers every use of the media, including use of the media for cultivating stem cells.
TGA approves first treatment for geographic atrophy
Australia has become the first country outside of the United States to approve the use of the...
Damaged RNA, not DNA, revealed as main cause of acute sunburn
Sunburn has traditionally been attributed to UV-induced DNA damage, but it turns out that this is...
Multi-ethnic studies identify new genes for depression
Two international studies have revealed hundreds of previously unknown genetic links to...
